Bladder Cancer Coverage from Every Angle

Pancreaticoduodenectomy for Metastasized Bladder Cancer: Case Report

By: Kayci Reyer
Posted: Thursday, January 6, 2022

A case study presented in the Annals of Hepato-Biliary-Pancreatic Surgery describes a pancreaticoduodenectomy performed on a man with metastatic bladder cancer. This is believed to be the first report of pancreatectomy for metastasis from bladder cancer. “We believe that curative resection for metastasis to [the] pancreas of urothelial carcinoma might be helpful for its management,” concluded So Jeong Lee, MD, of the Pusan National University School of Medicine in South Korea, and colleagues.

The 61-year-old patient presented with jaundice and and a mass on the pancreas head. He had undergone robot-assisted cystectomy and ileal conduit for high-grade (T3N0 without marginal involvement) bladder cancer 7 months prior. CT imaging identified a 3.6-cm, well-defined pancreatic mass, and MRI confirmed a well-defined mass on the pancreas head, leading to an initial diagnosis of pancreas head cancer. However, the pathologic diagnosis was a 4.9-cm metastatic urothelial carcinoma with lymph node metastasis, based on histologic findings and immunohistochemistry results.

The patient underwent a classic pancreaticoduodenectomy without complication. He was released from the hospital 11 days after the procedure. The surgery was followed by a four-cycle treatment regimen of gemcitabine and cisplatin. At a follow-up of 16 months, the patient had experienced no tumor recurrence.

Disclosure: The study authors reported no conflicts of interest.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.